XR Securities’s Bristol-Myers Squibb BMY Stock Holding History

XR Securities’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,902	Closed	-$200K	–	348
2023 Q4	$200K	Buy	+3,902	New	+$205K	0.01%	386
2023 Q2	–	Sell	-10,973	Closed	-$761K	–	389
2023 Q1	$761K	Sell	10,973 -260	-2%	-$18.3K	0.02%	214
2022 Q4	$808K	Buy	11,233 +6,469	+136%	+$488K	0.08%	193
2022 Q3	$339K	Buy	+4,764	New	+$346K	0.18%	103
2022 Q2	–	Sell	-9,968	Closed	-$759K	–	382
2022 Q1	$728K	Buy	9,968 +4,977	+100%	+$334K	0.13%	48
2021 Q4	$311K	Buy	+4,991	New	+$293K	0.03%	149
2020 Q1	–	Sell	-22,462	Closed	-$1.37M	–	217
2019 Q4	$1.44M	Buy	22,462 +7,994	+55%	+$458K	0.19%	30
2019 Q3	$734K	Buy	14,468 +4,113	+40%	+$193K	0.1%	43
2019 Q2	$470K	Buy	+10,355	New	+$482K	0.09%	69

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

XR Securities's BMY Position: Q1 2024 in Review

XR Securities sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 3,902 shares — an estimated $200K sold.

XR Securities first reported a position in BMY in Q2 2019 and held it in 9 quarters. The position peaked at $1.44M in Q4 2019. 2,338 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

XR Securities reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
XR Securities sold 3,902 Bristol-Myers Squibb shares in Q1 2024, an estimated $200K.
XR Securities first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 9 quarters.
XR Securities's Bristol-Myers Squibb position peaked at $1.44M in Q4 2019.
2,338 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on XR Securities's 13F filing for Q1 2024, filed 8 May 2024.